Stevenage, United Kingdom Saturday, January 10, 2026, 14:00 Hrs [IST] ...
In the past three weeks, a flurry of licensing deals with Chinese biotechs were announced featuring AbbVie, AstraZeneca, ...
NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...
Biogen Inc. (NASDAQ:BIIB) is one of the best performing pharma stocks in 2025. Biogen Inc. (NASDAQ:BIIB) received several ...
Astronomy on MSN
Jan. 8, 1942: The birth of Stephen Hawking
Today in the history of astronomy, one of the brightest and most famous scientific minds of the modern era is born.
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is one of the best performing pharma stocks in 2025. Amylyx Pharmaceuticals, Inc.
ALS is a rare and fatal disease that affects the nervous system, according to the Mayo Clinic. Also known as Lou Gehrig’s ...
The first edition of area girls basketball takeaways features Whitefish Bay with a huge win, while a MCC team's unbeaten run ...
Insmed outlines 2026 outlook, highlighting BRINSUPRI expansion, ARIKAYCE revenue guidance and multiple late-stage clinical ...
QRL-101, an oral small molecule being developed by QurAlis, was safe and reduced nerve-cell overactivity in ALS patients in ...
Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.
Interesting Engineering on MSN
Blink-powered eye tracker with 99% precision could let paralyzed patients control chairs
Researchers at Qingdao University in China have developed a lightweight, self-powered eye-tracking system designed to assist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback